Marc P Michalsky1, Thomas H Inge2, Mark Simmons3, Todd M Jenkins2, Ralph Buncher3, Michael Helmrath2, Mary L Brandt4, Carroll M Harmon5, Anita Courcoulas6, Michael Chen7, Mary Horlick8, Stephen R Daniels9, Elaine M Urbina2. 1. Nationwide Children's Hospital, Columbus, Ohio. 2. Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 3. University of Cincinnati, Cincinnati, Ohio. 4. Texas Children's Hospital, Baylor College of Medicine, Houston. 5. University of Buffalo, Buffalo, New York. 6. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 7. University of Alabama at Birmingham. 8. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. 9. Denver Children's Hospital, Denver, Colorado.
Abstract
IMPORTANCE: Severe obesity is increasingly common in the adolescent population but, as of yet, very little information exists regarding cardiovascular disease (CVD) risks in this group. OBJECTIVE: To assess the baseline prevalence and predictors of CVD risks among severely obese adolescents undergoing weight-loss surgery. DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort study was conducted from February 28, 2007, to December 30, 2011, at the following 5 adolescent weight-loss surgery centers in the United States: Nationwide Children's Hospital in Columbus, Ohio; Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio; Texas Children's Hospital in Houston; University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania; and Children's Hospital of Alabama in Birmingham. Consecutive patients aged 19 years or younger were offered enrollment in a long-term outcome study; the final analysis cohort consisted of 242 participants. MAIN OUTCOMES AND MEASURES: This report examined the preoperative prevalence of CVD risk factors (ie, fasting hyperinsulinemia, elevated high-sensitivity C-reactive protein levels, impaired fasting glucose levels, dyslipidemia, elevated blood pressure, and diabetes mellitus) and associations between risk factors and body mass index (calculated as weight in kilograms divided by height in meters squared), age, sex, and race/ethnicity. Preoperative data were collected within 30 days preceding bariatric surgery. RESULTS: The mean (SD) age was 17 (1.6) years and median body mass index was 50.5. Cardiovascular disease risk factor prevalence was fasting hyperinsulinemia (74%), elevated high-sensitivity C-reactive protein levels (75%), dyslipidemia (50%), elevated blood pressure (49%), impaired fasting glucose levels (26%), and diabetes mellitus (14%). The risk of impaired fasting glucose levels, elevated blood pressure, and elevated high-sensitivity C-reactive protein levels increased by 15%, 10%, and 6%, respectively, per 5-unit increase in body mass index (P < .01). Dyslipidemia (adjusted relative risk = 1.60 [95% CI, 1.26-2.03]; P < .01) and elevated blood pressure (adjusted relative risk = 1.48 [95% CI, 1.16-1.89]; P < .01) were more likely in adolescent boys compared with adolescent girls. White individuals were at greater risk of having elevated triglyceride levels (adjusted relative risk = 1.76 [95% CI, 1.14-2.72]; P = .01) but were less likely to have impaired fasting glucose levels (adjusted relative risk = 0.58 [95% CI, 0.38-0.89]; P = .01). CONCLUSIONS AND RELEVANCE: Numerous CVD risk factors are apparent in adolescents undergoing weight-loss surgery. Increasing body mass index and male sex increase the relative risk of specific CVD risk factors. These data suggest that even among severely obese adolescents, recognition and treatment of CVD risk factors is important to help limit further progression of disease.
IMPORTANCE: Severe obesity is increasingly common in the adolescent population but, as of yet, very little information exists regarding cardiovascular disease (CVD) risks in this group. OBJECTIVE: To assess the baseline prevalence and predictors of CVD risks among severely obese adolescents undergoing weight-loss surgery. DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort study was conducted from February 28, 2007, to December 30, 2011, at the following 5 adolescent weight-loss surgery centers in the United States: Nationwide Children's Hospital in Columbus, Ohio; Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio; Texas Children's Hospital in Houston; University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania; and Children's Hospital of Alabama in Birmingham. Consecutive patients aged 19 years or younger were offered enrollment in a long-term outcome study; the final analysis cohort consisted of 242 participants. MAIN OUTCOMES AND MEASURES: This report examined the preoperative prevalence of CVD risk factors (ie, fasting hyperinsulinemia, elevated high-sensitivity C-reactive protein levels, impaired fasting glucose levels, dyslipidemia, elevated blood pressure, and diabetes mellitus) and associations between risk factors and body mass index (calculated as weight in kilograms divided by height in meters squared), age, sex, and race/ethnicity. Preoperative data were collected within 30 days preceding bariatric surgery. RESULTS: The mean (SD) age was 17 (1.6) years and median body mass index was 50.5. Cardiovascular disease risk factor prevalence was fasting hyperinsulinemia (74%), elevated high-sensitivity C-reactive protein levels (75%), dyslipidemia (50%), elevated blood pressure (49%), impaired fasting glucose levels (26%), and diabetes mellitus (14%). The risk of impaired fasting glucose levels, elevated blood pressure, and elevated high-sensitivity C-reactive protein levels increased by 15%, 10%, and 6%, respectively, per 5-unit increase in body mass index (P < .01). Dyslipidemia (adjusted relative risk = 1.60 [95% CI, 1.26-2.03]; P < .01) and elevated blood pressure (adjusted relative risk = 1.48 [95% CI, 1.16-1.89]; P < .01) were more likely in adolescent boys compared with adolescent girls. White individuals were at greater risk of having elevated triglyceride levels (adjusted relative risk = 1.76 [95% CI, 1.14-2.72]; P = .01) but were less likely to have impaired fasting glucose levels (adjusted relative risk = 0.58 [95% CI, 0.38-0.89]; P = .01). CONCLUSIONS AND RELEVANCE: Numerous CVD risk factors are apparent in adolescents undergoing weight-loss surgery. Increasing body mass index and male sex increase the relative risk of specific CVD risk factors. These data suggest that even among severely obese adolescents, recognition and treatment of CVD risk factors is important to help limit further progression of disease.
Authors: Julia Steinberger; Stephen R Daniels; Robert H Eckel; Laura Hayman; Robert H Lustig; Brian McCrindle; Michele L Mietus-Snyder Journal: Circulation Date: 2009-01-12 Impact factor: 29.690
Authors: Sue Y S Kimm; Bruce A Barton; Eva Obarzanek; Robert P McMahon; Shari S Kronsberg; Myron A Waclawiw; John A Morrison; George B Schreiber; Zak I Sabry; Stephen R Daniels Journal: Pediatrics Date: 2002-11 Impact factor: 7.124
Authors: Steven H Belle; Paul D Berk; Anita P Courcoulas; David R Flum; Carolyn W Miles; James E Mitchell; Walter J Pories; Bruce M Wolfe; Susan Z Yanovski Journal: Surg Obes Relat Dis Date: 2007 Mar-Apr Impact factor: 4.734
Authors: Mary L Brandt; Carroll M Harmon; Michael A Helmrath; Thomas H Inge; Siripoom V McKay; Marc P Michalsky Journal: Nat Rev Endocrinol Date: 2010-09-14 Impact factor: 43.330
Authors: Marc P Michalsky; Thomas H Inge; Todd M Jenkins; Changchun Xie; Anita Courcoulas; Michael Helmrath; Mary L Brandt; Carroll M Harmon; Mike Chen; John B Dixon; Elaine M Urbina Journal: Pediatrics Date: 2018-01-08 Impact factor: 7.124
Authors: T Dylan Olver; Zachary I Grunewald; Thomas J Jurrissen; Rebecca E K MacPherson; Paul J LeBlanc; Teagan R Schnurbusch; Alana M Czajkowski; M Harold Laughlin; R Scott Rector; Shawn B Bender; Eric M Walters; Craig A Emter; Jaume Padilla Journal: Am J Physiol Regul Integr Comp Physiol Date: 2017-12-04 Impact factor: 3.619
Authors: Lindel C Dewberry; Anahita Jalivand; Resmi Gupta; Todd M Jenkins; Andrew Beamish; Thomas H Inge; Anita Courcoulas; Michael Helmrath; Mary L Brandt; Carroll M Harmon; Mike Chen; John B Dixon; Margaret Zeller; Marc P Michalsky Journal: Obes Surg Date: 2020-06 Impact factor: 4.129
Authors: Ramon Vilallonga; José Manuel Moreno Villares; Diego Yeste Fernández; Raquel Sánchez Santos; Felipe Casanueva Freijo; Francisco Santolaya Ochando; Nuria Leal Hernando; Albert Lecube Torelló; Luis Antonio Castaño González; Albert Feliu; Gontrand Lopez-Nava; Dolores Frutos; Felipe de la Cruz Vigo; Antonio J Torres Garcia; Juan Carlos Ruiz de Adana Journal: Obes Surg Date: 2017-04 Impact factor: 4.129
Authors: Vidhu V Thaker; Felix Lee; Clement J Bottino; Cassandra L Perry; Ingrid A Holm; Joel N Hirschhorn; Stavroula K Osganian Journal: Clin Pediatr (Phila) Date: 2015-12-15 Impact factor: 1.168
Authors: Lauren A Sarno; Steven E Lipshultz; Carroll Harmon; Nestor F De La Cruz-Munoz; Preetha L Balakrishnan Journal: Pediatr Res Date: 2019-08-11 Impact factor: 3.756
Authors: J Lopez-Sandoval; S Sanchez-Enriquez; E A Rivera-Leon; B E Bastidas-Ramirez; M R Garcia-Garcia; M E Gonzalez-Hita Journal: Acta Endocrinol (Buchar) Date: 2018 Jul-Sep Impact factor: 0.877
Authors: Dennis M Styne; Silva A Arslanian; Ellen L Connor; Ismaa Sadaf Farooqi; M Hassan Murad; Janet H Silverstein; Jack A Yanovski Journal: J Clin Endocrinol Metab Date: 2017-03-01 Impact factor: 5.958